Literature DB >> 8818540

The chemokine C10: immunological and functional analysis of the sequence encoded by the novel second exon.

M S Berger1, D D Taub, A Orlofsky, T R Kleyman, B Coupaye-Gerard, D Eisner, S A Cohen.   

Abstract

The gene for C10, a member of the beta-chemokine family of cytokines, contains a novel second exon encoding a 16 amino acid sequence which is inserted into the amino-terminal region of the protein. We propose a model of C10 structure in which the sequence encoded by the second exon is located on the surface of the protein where it interacts with receptors and defines the predominant epitope of the C10 protein. To test this model we produced C10 protein without the sequence encoded by the second exon, termed C10(-). Antisera generated against purified C10 recognized C10 protein but reacted only weakly with C10(-) protein. Recognition of C10 protein by C10 antisera was not blocked by pre-incubation with a peptide encoding the C10 second exon, indicating that the predominant epitope was not simply the amino acid sequence encoded by the second exon. Antibodies generated against a peptide encoding the C10 second exon sequence recognized C10 on Western blots; this reaction was competed both by C10 second exon peptide and by C10 protein. Functional studies demonstrated that both C10/FLAG and C10(-)/FLAG elicit chemotaxis of mouse PECs and human PBMCs, but that C10(-)/FLAG appears to be more potent than C10/FLAG. Thus these data are consistent with our model of C10 in which the sequence encoded by the second exon is located on the surface, participates in defining the predominant epitope, and plays a key role in recognizing or activating chemokine receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8818540     DOI: 10.1006/cyto.1996.0060

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

1.  Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells.

Authors:  Sabrina Mancardi; Elena Vecile; Nelson Dusetti; Ezequiel Calvo; Giorgio Stanta; Oscar R Burrone; Aldo Dobrina
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

2.  C10 is a novel chemokine expressed in experimental inflammatory demyelinating disorders that promotes recruitment of macrophages to the central nervous system.

Authors:  V C Asensio; S Lassmann; A Pagenstecher; S C Steffensen; S J Henriksen; I L Campbell
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

3.  Chemokine C10 promotes disease resolution and survival in an experimental model of bacterial sepsis.

Authors:  M L Steinhauser; C M Hogaboam; A Matsukawa; N W Lukacs; R M Strieter; S L Kunkel
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

4.  CC chemokine receptor-1 activates intimal smooth muscle-like cells in graft arterial disease.

Authors:  Koichi Shimizu; Manabu Minami; Rica Shubiki; Marco Lopez-Ilasaca; Lindsey MacFarlane; Yukiko Asami; Yuxin Li; Richard N Mitchell; Peter Libby
Journal:  Circulation       Date:  2009-10-19       Impact factor: 29.690

5.  The role of macrophage class a scavenger receptors in a laser-induced murine choroidal neovascularization model.

Authors:  Shayma Jawad; Baoying Liu; Zhiyu Li; Robert Katamay; Mercedes Campos; Lai Wei; H Nida Sen; Diamond Ling; Fernando Martinez Estrada; Juan Amaral; Chi-Chao Chan; Robert Fariss; Siamon Gordon; Robert B Nussenblatt
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-05       Impact factor: 4.799

Review 6.  Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development.

Authors:  Valérie Gouon-Evans; Elaine Y Lin; Jeffrey W Pollard
Journal:  Breast Cancer Res       Date:  2002-06-25       Impact factor: 6.466

7.  Omental macrophages secrete chemokine ligands that promote ovarian cancer colonization of the omentum via CCR1.

Authors:  Venkatesh Krishnan; Supreeti Tallapragada; Bruce Schaar; Kalika Kamat; Anita M Chanana; Yue Zhang; Sonia Patel; Vinita Parkash; Carrie Rinker-Schaeffer; Ann K Folkins; Erinn B Rankin; Oliver Dorigo
Journal:  Commun Biol       Date:  2020-09-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.